SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
88 hedge funds and large institutions have $98.7M invested in scPharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.82% less ownership
Funds ownership: 79.49% → 74.67% (-4.8%)
30% less capital invested
Capital invested by funds: $141M → $98.7M (-$42.1M)
Holders
88
Holding in Top 10
1
Calls
$400K
Puts
$13K
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.07M | |
| 3 | +$692K | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$526K |
| 5 |
ACA
Apis Capital Advisors
New York
|
+$292K |
Top Sellers
| 1 | -$6.52M | |
| 2 | -$1.87M | |
| 3 | -$1.66M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.05M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$883K |